Literature DB >> 31764391

Reducing the use of opioids by patients with chronic pain: an effectiveness study with long-term follow-up.

Michael K Nicholas1,2, Ali Asghari1,2,3, Louise Sharpe4, Lee Beeston1,2, Charles Brooker1,2, Paul Glare1,2, Rebecca Martin1,2, Allan Molloy1,2, Paul J Wrigley1,2.   

Abstract

This study addresses the problem of long-term opioid use by chronic pain patients. The study involved a secondary analysis of unanalyzed data from a published study of 2 versions of cognitive-behavioural therapy-based interdisciplinary treatment for chronic pain. In this study, we examined whether the use of opioids by 140 chronic pain patients could be ceased sustainably over 12 months after participation in the comprehensive interdisciplinary pain management program aimed at enhancing pain self-management. On admission to the treatment, there were no significant differences between those patients taking or not taking opioids on usual pain, pain interference in daily activities, pain-related disability, depression severity, as well as in pain cognitions. After the treatment, the use of opioids was significantly reduced, both in numbers taking any and in mean doses, and these gains were maintained over the 12-month follow-up. Finally, cessation of opioids during treatment was associated with more substantial and consistent improvements in usual pain, depression severity, pain interference, pain-related disability, and pain cognitions, relative to those who reduced their opioids but did not cease them. These findings support the idea of using training in pain self-management strategies as a viable alternative to long-term opioid use by patients with chronic pain.

Entities:  

Year:  2020        PMID: 31764391     DOI: 10.1097/j.pain.0000000000001763

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

1.  Role of Rehabilitation in Opioid Tapering: A Scoping Review.

Authors:  Miranda Wiens; Devon Jarrett; Alissa Settimi; Courtney White; Zachary Hollingham; Tara Packham
Journal:  Physiother Can       Date:  2021-06-07       Impact factor: 1.037

2.  Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review.

Authors:  Katherine Mackey; Johanna Anderson; Donald Bourne; Emilie Chen; Kim Peterson
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

3.  "Living Well with Chronic Pain": Integrative Pain Management via Shared Medical Appointments.

Authors:  Josie Znidarsic; Kellie N Kirksey; Stephen M Dombrowski; Anne Tang; Rocio Lopez; Heather Blonsky; Irina Todorov; Dana Schneeberger; Jonathan Doyle; Linda Libertini; Starkey Jamie; Tracy Segall; Andrew Bang; Kathy Barringer; Bar Judi; Jane Pernotto Ehrman; Michael F Roizen; Mladen Golubić
Journal:  Pain Med       Date:  2021-02-04       Impact factor: 3.750

4.  Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year follow-up in a subset of patients.

Authors:  Maisa Ziadni; Abby L Chen; Parthasarathy Krishnamurthy; Pamela Flood; Richard L Stieg; Beth D Darnall
Journal:  Pain Rep       Date:  2020-09-17

5.  Perspectives of pain specialists, patients, and family members on long-term opioid use for chronic non-cancer pain: a qualitative study.

Authors:  Rattaphol Seangrung; Thongchai Tempeetikul; Supasit Pannarunothai; Supalak Sakdanuwatwong
Journal:  BMC Anesthesiol       Date:  2021-11-09       Impact factor: 2.217

6.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04

7.  Evaluating acceptability and feasibility of a mobile health intervention to improve self-efficacy in prescription opioid tapering in patients with chronic pain: protocol for a pilot randomised, single-blind, controlled trial.

Authors:  Michael Magee; Ali Gholamrezaei; Amy Gray McNeilage; Leah Dwyer; Alison Sim; Manuela Ferreira; Beth Darnall; Paul Glare; Claire Ashton-James
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.